L. Li

机构：Shanghai Medical College of Fudan University · ORCID：0009-0009-4088-4430

发表论文 36 篇 · 总被引 72 次 · h-index 4

代表论文

• CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell Lymphoma (2024 · Cancer Research · 被引 29)
• Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B‐Cell Lymphoma: A Real‐World, Multi‐Center, Retrospective Cohort Study (2024 · Hematological Oncology · 被引 17)
• Differential expression pattern of CC chemokine receptor 7 guides precision treatment of hepatocellular carcinoma (2025 · Signal Transduction and Targeted Therapy · 被引 11)
• Akkermansia muciniphila reduces neuroinflammation and Aβ deposition via tryptophan metabolism in the APP/PS1 mouse model of Alzheimer’s disease (2026 · Alzheimer s Research & Therapy · 被引 7)
• Single-cell and bulk transcriptomics reveal a CD8+ T-cell gene signature predicting prognosis in diffuse large B-cell lymphoma (2025 · Frontiers in Immunology · 被引 2)
• Clinical Features and Outcomes of Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified, Treated with CHOP-Based Regimens (2025 · Cancers · 被引 2)